Clinical Diagnostics Technology & Disease Research News | 360Dx
WEBQiagen Targets Oncohematology, Companion Diagnostics Space With Clinical Digital PCR Instrument. The firm launched the QiAcuityDx system on Monday and will seek US Food and Drug Administration 510 (k) clearance along with a BCR-ABL assay. The authors of a commentary said they view recent study results as informative, though limited, regarding ...
Healgen Gains FDA Marketing Authorization for OTC COVID, Flu …
WEB22 hours ago · NEW YORK – The US Food and Drug Administration said on Monday that it has granted marketing authorization for Healgen Scientific's home-use combination test for flu and COVID-19. While the agency has previously granted Emergency Use Authorizations for multiple home-use combination tests, Healgen's Rapid Check COVID-19/Flu A&B Antigen Test is ...
Gradientech Wins Hardy Diagnostics as Investor, North American ...
WEB15 hours ago · NEW YORK – Gradientech said on Tuesday that Hardy Diagnostics will distribute its QuickMIC antibiotic susceptibility testing system in the US and Canada and is becoming an investor of the Swedish company. Hardy Diagnostics will invest an undisclosed amount in Uppsala-based Gradientech …
Top Five Articles on 360Dx Last Week: Roche’s New PCR …
WEB1 day ago · NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: 1) Roche Leveraging New PCR Technology for 12-Target Respiratory Test 2) FDA Clears Abionic Point-of-Care Sepsis Test https 3) As Digital Pathology Slowly Expands, Industry Anxiously Awaits a Breakout Moment 4) Owlstone Medical, FDA to Develop Breath-Based Disease Detection ...
About Us - 360Dx
WEBAbout Us. 360Dx is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a family brand of Crain ...
Lumos Diagnostics Sets Stage for US Expansion With New …
WEB4 days ago · NEW YORK –With nearly $10 million in recent contracts and financing, and new distribution agreements in place, Australian infectious disease company Lumos Diagnostics hopes to obtain CLIA waiver for its FebriDx rapid host-response test next year to catalyze its US expansion. This week, Lumos announced a $3 …
Exact Sciences Nabs FDA Approval for Cologuard Plus Assay
WEB4 days ago · Save for later. NEW YORK – Exact Sciences announced on Friday that its next-generation Cologuard Plus test has received approval from the US Food and Drug Administration. The multitarget stool DNA test was approved for use in adults ages 45 and older who are at average risk for colorectal cancer. The …
Diagnostic Technologies and Applications - 360Dx
WEBSep 19, 2024. New Multi-Cancer Detection Data Speak to Both Promises and Cautions of Blood-Based Assays. Sep 18, 2024. Hedera Dx Expects Increased Liquid Biopsy Adoption With Real-World Data Cancer Registries. News and analysis on diagnostic technologies and applications from 360Dx.
Harvard Researchers Develop AI-Based Model for Cancer Dx, …
WEBSep 6, 2024 · NEW YORK – Researchers from Harvard Medical School have developed a new artificial intelligence-based model for systematically diagnosing multiple cancer types and predicting patients' prognoses from digital pathology images. Described in a paper published this week in Nature, the Clinical Histopathology …
coronavirus Diagnostics News | 360Dx
WEBcoronavirus. Breaking news on coronavirus testing, with real-time reporting on assays to detect the SARS-CoV2 coronavirus, which causes COVID-19. Check out our Coronavirus Test Tracker for the latest information on the regulatory status of these tests in the US, European, and Asian markets.